volume 16 issue 7 pages 968-1001

Flavones as a Privileged Scaffold in Drug Discovery: Current Developments

Publication typeJournal Article
Publication date2019-07-23
scimago Q3
wos Q2
SJR0.377
CiteScore4.0
Impact factor2.5
ISSN15701794, 18756271
Organic Chemistry
Biochemistry
Abstract
Background:

Flavones are one of the main subclasses of flavonoids with diverse pharmacological properties. They have been reported to possess antimalarial, antimicrobial, anti-tuberculosis, anti-allergic, antioxidant, anti-inflammatory activities, among others.

Objective:

The present review summarizes the recent information on the pharmacological properties of naturally occurring and synthetic flavones.

Method:

Scientific publications referring to natural and synthetic flavones in relation to their biological activities were hand-searched in databases such as SciFinder, PubMed (National Library of Medicine), Science Direct, Wiley, ACS, SciELO, Springer, among others.

Results:

As per the literature, seventy-five natural flavones were predicted as active compounds with reference to their IC50 (<20 µg/mL) in in vitro studies. Also, synthetic flavones were found active against several diseases.

Conclusion:

As per the literature, flavones are important sources for the potential treatment of multifactorial diseases. However, efforts toward the development of flavone-based therapeutic agents are still needed. The appearance of new catalysts and chemical transformations is expected to provide avenues for the synthesis of unexplored flavones, leading to the discovery of flavones with new properties and biological activities.

Found 
Found 

Top-30

Journals

1
2
Journal of Agricultural and Food Chemistry
2 publications, 5.88%
Pharmaceuticals
2 publications, 5.88%
Frontiers in Pharmacology
2 publications, 5.88%
Journal of Fluorine Chemistry
2 publications, 5.88%
Phytomedicine
2 publications, 5.88%
Journal of Molecular Structure
2 publications, 5.88%
Central Nervous System Agents in Medicinal Chemistry
1 publication, 2.94%
Phytochemical Analysis
1 publication, 2.94%
Biological and Pharmaceutical Bulletin
1 publication, 2.94%
Journal of Physical Chemistry A
1 publication, 2.94%
Processes
1 publication, 2.94%
Biomolecules
1 publication, 2.94%
International Journal of Molecular Sciences
1 publication, 2.94%
Chinese Medicine
1 publication, 2.94%
Membranes
1 publication, 2.94%
Phytotherapy Research
1 publication, 2.94%
ChemistrySelect
1 publication, 2.94%
Asian Journal of Chemistry
1 publication, 2.94%
Organic and Biomolecular Chemistry
1 publication, 2.94%
Molecular Diversity
1 publication, 2.94%
Pharmacia
1 publication, 2.94%
Russian Chemical Reviews
1 publication, 2.94%
Organic Process Research and Development
1 publication, 2.94%
Journal of Drug Delivery Science and Technology
1 publication, 2.94%
Drugs and Drug Candidates
1 publication, 2.94%
ChemMedChem
1 publication, 2.94%
Reactions
1 publication, 2.94%
Digital Chinese Medicine
1 publication, 2.94%
1
2

Publishers

1
2
3
4
5
6
7
8
MDPI
8 publications, 23.53%
Elsevier
8 publications, 23.53%
Wiley
4 publications, 11.76%
American Chemical Society (ACS)
4 publications, 11.76%
Frontiers Media S.A.
2 publications, 5.88%
Springer Nature
2 publications, 5.88%
Bentham Science Publishers Ltd.
1 publication, 2.94%
Pharmaceutical Society of Japan
1 publication, 2.94%
Asian Journal of Chemistry
1 publication, 2.94%
Royal Society of Chemistry (RSC)
1 publication, 2.94%
Pensoft Publishers
1 publication, 2.94%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 2.94%
1
2
3
4
5
6
7
8
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
34
Share
Cite this
GOST |
Cite this
GOST Copy
Boniface P. K., Elizabeth F. I. Flavones as a Privileged Scaffold in Drug Discovery: Current Developments // Current Organic Synthesis. 2019. Vol. 16. No. 7. pp. 968-1001.
GOST all authors (up to 50) Copy
Boniface P. K., Elizabeth F. I. Flavones as a Privileged Scaffold in Drug Discovery: Current Developments // Current Organic Synthesis. 2019. Vol. 16. No. 7. pp. 968-1001.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.2174/1570179416666190719125730
UR - https://doi.org/10.2174/1570179416666190719125730
TI - Flavones as a Privileged Scaffold in Drug Discovery: Current Developments
T2 - Current Organic Synthesis
AU - Boniface, Pone K.
AU - Elizabeth, Ferreira I.
PY - 2019
DA - 2019/07/23
PB - Bentham Science Publishers Ltd.
SP - 968-1001
IS - 7
VL - 16
PMID - 31984880
SN - 1570-1794
SN - 1875-6271
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2019_Boniface,
author = {Pone K. Boniface and Ferreira I. Elizabeth},
title = {Flavones as a Privileged Scaffold in Drug Discovery: Current Developments},
journal = {Current Organic Synthesis},
year = {2019},
volume = {16},
publisher = {Bentham Science Publishers Ltd.},
month = {jul},
url = {https://doi.org/10.2174/1570179416666190719125730},
number = {7},
pages = {968--1001},
doi = {10.2174/1570179416666190719125730}
}
MLA
Cite this
MLA Copy
Boniface, Pone K., and Ferreira I. Elizabeth. “Flavones as a Privileged Scaffold in Drug Discovery: Current Developments.” Current Organic Synthesis, vol. 16, no. 7, Jul. 2019, pp. 968-1001. https://doi.org/10.2174/1570179416666190719125730.